Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors

Cancer Detection and Prevention

Volumn 32, Issue 4, 2009, Pages 300-307

  Illades Aguiar, Berenice ^a   Cortés Malagón, Enoc Mariano ^a   Antonio Véjar, Verónica ^a   Zamudio López, Noelio ^a   Alarcón Romero, Luz del Carmen ^a   Fernández Tilapa, Gloria ^a   Hernández Sotelo, Daniel ^a   Terán Porcayo, Marco Antonio ^b   Flores Alfaro, Eugenia ^a   Leyva Vázquez, Marco Antonio ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b Instituto Estatal de Cancerologia Dr Arturo Beltran Ortega   (Mexico)

Author keywords

Cervical cancer co factors; Cervical cancer in Latin America; Cervical cancer in Mexico; Cervical cancer risk; HPV PCR detection; HPV typing; Human papillomavirus and cervical cancer; Human papillomavirus epidemiology in Mexico; Human papillomavirus genotypes in Mexico; Human papillomavirus in normal cervix

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENOTYPE; HIGH RISK BEHAVIOR; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; MEXICO; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEXUAL INTERCOURSE; UNSAFE SEX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS ETIOLOGY; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

ADENOCARCINOMA; ADULT; AGE FACTORS; ALPHAPAPILLOMAVIRUS; CARCINOMA, ADENOSQUAMOUS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MEXICO; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; REPRODUCTIVE HISTORY; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 60749133309     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.09.001     Document Type: Article

References (39)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002 cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No. 5 version 2.0. Lyon: IARC Press; 2004.
2. Lazcano-Ponce E.C., Nájera-Aguilar P., Buiatti E., Alonso de Ruiz P., Kuri P., Cantoral L., et al. The cervical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control 8 (1997) 698-704
3. Arrossi S., Sankaranarayanan R., and Parkin D.M. Incidence and mortality of cervical cancer in Latin America. Salud Pública Mex 45 (2003) S306-S314
4. Lazcano-Ponce E., Herrero R., Muñoz N., Cruz A., Shah K.V., Alonso P., et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 91 (2001) 412-420
5. Palacio-Mejía L.S., Rangel-Gómez G., Hernández-Avila M., and Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Pública Mex 45 (2003) S315-S325
6. Secretaría de Salud. Dirección General de Información en Salud. Mexico, 2006. Available from URL: http://sinais.salud.gob.mx/ [Last accessed: 2007 May 8].
7. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
8. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
9. Cogliano V., et al. Carcinogenicity of human papillomavirus. Lancet Oncol 6 (2005) 204
10. Muñoz N., Castellsagué X., Berrington de González A., and Gissmann L. HPV in the etiology of human cancer. Vaccine 24S3 (2006) S3/1-10
11. Calleja-Macías I.E., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., et al. Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and-b. J Virol 79 (2005) 6565-6569
12. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87 (1995) 796-802
13. Torroella-Kouri M., Morsberger S., Carrillo A., Mohar A., Meneses A., Ibarra M., et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 70 (1998) 115-120
14. Hernández-Hernández D.M., García-Carrancá A., Guido-Jiménez M.C., González-Sánchez J.L., Cruz-Talonia F., Apresa-García T., et al. High-risk human papillomavirus and cervical intraepithelial neoplasia in women at 2 hospitals in Mexico City. Rev Invest Clin 54 (2002) 299-306
15. Castañeda-Iñiguez M.S., Toledo-Cisneros R., and Aguilera-Delgadillo M. Risk factors for cervico-uterine cancer in women in Zacatecas. Salud Pública Mex 40 (1998) 330-338
16. Lazcano-Ponce E.C., Hernández-Avila M., López-Carrillo L., Alonso de Ruiz P., Torres-Lobatón A., González-Lira G., et al. Reproductive risk factors and sexual history associated with cervical cancer in Mexico. Rev Invest Clin 47 (1995) 377-385
17. Tirado-Gómez L.L., Mohar-Betancourt A., López-Cervantes M., García-Carrancá A., Franco-Marina F., and Borges G. Risk factors in invasive cervical cancer among Mexican women. Salud Pública Mex 47 (2005) 342-350
18. FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obst 70 (2000) 207-312
19. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
20. Leornard D., Michael K., and James B. Basic methods in molecular biology. 2nd ed. (1994), Appleton & Lange, Connecticut
21. Bauer H.M., Greer C.E., and Manos M.M. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington C.S., and McGee J.O. (Eds). Diagnostic molecular pathology: a practical approach (1992), Oxford University Press, Oxford 131-152
22. Bauer H.M., and Manos M.M. PCR detection of genital human papillomavirus. In: Persing D.H., Smith T.F., Tenover F.C., and White T.J. (Eds). Diagnostic molecular microbiology, principles and applications (1993), American Society for Microbiology, Washington 407-413
23. Vossler J.L., Forbes B.A., and Adelson M.D. Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J Med Virol 45 (1995) 354-360
24. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170 (1994) 1077-1085
25. Casas L., Galvan S.C., Ordoñez R.M., Lopez N., Guido M., and Berumen J. Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83 (1999) 449-455
26. Xin C.Y., Matsumoto K., Yoshikawa H., Yasugi T., Onda T., Nakagawa S., et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170 (2001) 19-24
27. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (1995) 412-417
28. National Center for Biotechnology Information. U.S. National Library of Medicine. Bethesda, MD. Available from URL: http://www.ncbi.nlm.nih.gov/BLAST/ [Last accessed: 2007 May 8].
29. Castellsagué X., Díaz M., Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98 (2006) 303-315
30. Clifford G.M., Smith J.S., Plummer M., Muñoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
31. Muñoz N., Bosch F.X., Castellsagué X., Díaz M., Sanjosé S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
32. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J.F., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
33. Gonzalez-Losa M.R., Rosado-López I., Valdez-Gonzalez N., and Puerto-Solis M. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 29 (2004) 202-205
34. Brink A., Snijders P., and Meijer C. HPV detection methods. Dis Markers 23 (2007) 273-281
35. Giuliano A., Papenfuss M., Brown de Galaz E.M., Feng J., Abrahamsen M., Denman C., et al. Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border. Int J Cancer 109 (2004) 112-118
36. Poljak M., Fujs K., Seme K., Kocjan B.J., and Vrtacnik-Bokal E. Retrospective and prospective evaluation of the amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples. Acta Dermatoven APA 14 (2005) 147-152
37. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
38. Castellsagué X., Bosch X., and Muñoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 89 (2002) 191-199
39. Illades-Aguiar B., Ortiz-Ortiz J., Cornejo-Ortega H., Zamudio-López N., Leyva-Vázquez M.A., and Barrientos-Garzón V.H. Human papillomavirus infection in male from Southern of Mexico. 21st International Conference Papillomavirus and Clinical Workshop (2004) 205